The characterization of tumor composition is important, as mucin-containing rectal carcinomas are associated with microsatellite instability, BRAF and KRAS mutations, and MUC-2 overexpression—genetic conditions that may have treatment implications. This evidence concerns the gene MUC5AC and neoplasm.